• High-throughput screening uses robots to test the actions of thousands of compounds against a molecular disease target (itself identified by genomics).

    FORBES: A hail of silver bullets

  • Scientists probing the molecular origins of heart disease are discovering surprising parallels between these two kinds of disorders, paving the way for new treatments.

    FORBES: Prevention Puzzle

  • The MRC-NIHR Phenome Centre will look for new molecular 'biomarkers' for disease by analysing samples from patients and volunteers.

    BBC: Legacy for anti-doping centre

  • Into this gloom comes Novartis' Glivec, the first leukemia drug designed to attack the molecular machinery that drives the disease.

    FORBES: The Race for a Cure

  • SU-11248 is one of a new spate of cancer pills that work by targeting several of the molecular defects that cause the disease at one time.

    FORBES: Pfizer Cancer Pill Proves Effective

  • "My vision is that we will have drugs targeting key elements of molecular pathways" that go awry in disease, Fishman says.

    FORBES: Magazine Article

  • By 2000, scientists had identified nearly 40 other genes involved in the disease, as well as various other molecular changes that cause muscles to waste away.

    WSJ: New Muscular Dystrophy Drugs Offer Hope

  • "The disease is common, but the fatalities are the puzzle we're trying to figure out, " says Dr. Jim Alexander, a molecular virologist with the Atlanta-based Centers for Disease Control and Prevention.

    CNN: Why Are the Infants Dying?

  • When Schleifer, a 50-year-old neurologist, cofounded Regeneron with George Yancopoulos , a molecular immunologist, the main target was Lou Gehrig's disease.

    FORBES: Hunger Pangs

  • The University of Colorado researchers are studying molecular mechanisms of normal acclimatization in healthy people to gain new treatment ideas for people with chronic obstructive pulmonary disease, or COPD, a common lung disease.

    WSJ: Mayo Clinic Researchers on Everest Study High Altitude's Effects on the Body

  • "Obesity is a disease that is crippling the healthcare system, " says Stephen Friend , Merck's vice president of molecular profiling.

    FORBES: Magazine Article

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定